US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.190
  • +0.015+0.69%
Close Dec 20 16:00 ET
  • 2.180
  • -0.010-0.45%
Post 19:56 ET
431.51MMarket Cap-3.27P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Esperion Therapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
51.71M
51.63M
-81.62K
Miss Est.
+52.24%
+52.00%
-0.16%
EPS
-0.18
-0.15
+0.03
Beat Est.
+52.64%
+59.46%
+14.38%
Analyst Rating
Buy

Dec 18, 2024

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.303M--
--2024/Q4-- / 62.141M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.303M--
--2024/Q4-- / 62.141M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--

Unlock Free Earnings Estimates

Esperion Therapeutics Earnings Reports

  • Esperion Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:29 ET

  • Esperion Therapeutics | 8-K: Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update

    Nov 7 07:23 ET

  • Esperion Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 16:12 ET

  • Esperion Therapeutics | 8-K: Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 12 07:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 18, 2024

    Buy

    • Buy

      71.43%

    • Hold

      14.29%

    • Sell

      14.29%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data